Author/Creator: Flamm, S. L. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Flamm, S. L.

1. Disparate access to treatment regimens in chronic hepatitis C patients: data from the TRIO network. Issue 6 (3rd February 2016)

Authors:: Younossi, Z. M.; Bacon, B. R.; Dieterich, D. T.; Flamm, S. L.; Kowdley, K.; Milligan, S.; Tsai, N.; Nezam, A.
Journal:: Journal of viral hepatitis
Issue:: Volume 23:Issue 6(2016)
Page Start:: 447
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Editorial: real‐life data confirm efficacy of elbasvir/grazoprevir in HCV patients with severe kidney disease—Author's reply. Issue 2 (25th June 2018)

Authors:: Flamm, S. L.
Journal:: Alimentary pharmacology & therapeutics
Issue:: Volume 48:Issue 2(2018)
Page Start:: 227
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Effectiveness of 8‐ or 12‐weeks of ledipasvir and sofosbuvir in real‐world treatment‐naïve, genotype 1 hepatitis C infected patients. Issue 5 (10th July 2017)

Authors:: Curry, M. P.; Tapper, E. B.; Bacon, B.; Dieterich, D.; Flamm, S. L.; Guest, L.; Kowdley, K. V.; Lee, Y.; Milligan, S.; Tsai, N.; Younossi, Z.; Afdhal, N. H.
Journal:: Alimentary pharmacology & therapeutics
Issue:: Volume 46:Issue 5(2017)
Page Start:: 540
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Real‐world effectiveness for 12 weeks of ledipasvir–sofosbuvir for genotype 1 hepatitis C: the Trio Health study. Issue 1 (11th October 2016)

Authors:: Tapper, E. B.; Bacon, B. R.; Curry, M. P.; Dieterich, D. T.; Flamm, S. L.; Guest, L. E.; Kowdley, K. V.; Lee, Y.; Tsai, N. C.; Younossi, Z. M.; Afdhal, N. H.
Journal:: Journal of viral hepatitis
Issue:: Volume 24:Issue 1(2017)
Page Start:: 22
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Real‐world use of elbasvir‐grazoprevir in patients with chronic hepatitis C: retrospective analyses from the TRIO network. Issue 11 (17th April 2018)

Authors:: Flamm, S. L.; Bacon, B.; Curry, M. P.; Milligan, S.; Nwankwo, C. U.; Tsai, N.; Younossi, Z.; Afdhal, N.
Journal:: Alimentary pharmacology & therapeutics
Issue:: Volume 47:Issue 11(2018)
Page Start:: 1511
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗